Regulatory T cell-enhancing therapies to treat atherosclerosis

H Ait-Oufella, JR Lavillegrand, A Tedgui - Cells, 2021 - mdpi.com
Experimental studies have provided strong evidence that chronic inflammation triggered by
the sub-endothelial accumulation of cholesterol-rich lipoproteins in arteries is essential in …

Treating atherosclerosis with regulatory T cells

AC Foks, AH Lichtman, J Kuiper - Arteriosclerosis, thrombosis, and …, 2015 - Am Heart Assoc
Regulatory T cells (Tregs) play an important role in the regulation of T-cell–mediated
immune responses through suppression of T-cell proliferation and secretion of inhibitory …

Regulatory T cells as a new therapeutic target for atherosclerosis

H Ou, B Guo, Q Liu, Y Li, Z Yang, W Feng… - Acta Pharmacologica …, 2018 - nature.com
Atherosclerosis is an autoimmune disease caused by self-and non-self-antigens
contributing to excessive activation of T and B cell immune responses. These responses …

T regulatory cells: a promising new target in atherosclerosis

K Tselios, A Sarantopoulos… - Critical Reviews™ in …, 2014 - dl.begellhouse.com
ABSTRACT T regulatory cells (Tregs) comprise the cardinal mechanism of peripheral
immune tolerance by modulating the function of virtually each immune cell. Given that …

Regulatory T cells in atherosclerosis: is adoptive cell therapy possible?

AV Churov, YS Chegodaev, VA Khotina, VP Ofitserov… - Life, 2023 - mdpi.com
Simple Summary Atherosclerosis is a vascular disease with an asymptomatic debut and
development over decades. The mechanisms of progression of atherosclerosis are not …

Getting to the heart of the matter: the role of regulatory T-cells (Tregs) in cardiovascular disease (CVD) and atherosclerosis

CJ Albany, SC Trevelin, G Giganti, G Lombardi… - Frontiers in …, 2019 - frontiersin.org
Cardiovascular diseases (CVD) are the leading cause of mortality worldwide.
Atherosclerosis is directly associated with CVD and is characterized by slow progressing …

Recent advances on the role and therapeutic potential of regulatory T cells in atherosclerosis

T Tanaka, N Sasaki, Y Rikitake - Journal of Clinical Medicine, 2021 - mdpi.com
Atherosclerotic diseases, including ischemic heart disease and stroke, are a main cause of
mortality worldwide. Chronic vascular inflammation via immune dysregulation is critically …

[PDF][PDF] Regulatory T cell immunity in atherosclerosis

HZ Amin, N Sasaki, KI Hirata - Acta Med. Indones, 2017 - researchgate.net
Atherosclerosis is a chronic inflammatory disorder involving innate and adaptive immunity
process. Effector T cell (Teff) responses promote atherosclerotic disease, whereas …

Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential

C Spitz, H Winkels, C Bürger, C Weber… - Cellular and molecular …, 2016 - Springer
Atherosclerosis is a chronic inflammatory disease that is mediated by innate and adaptive
immune responses. The disease is characterized by sub-endothelial accumulation and …

Treg cells in atherosclerosis

R Kuan, DK Agrawal, FG Thankam - Molecular Biology Reports, 2021 - Springer
Atherosclerosis involves both innate and adaptive immunity. Here, we provide an overview
of the role of regulatory T (Treg) cells in atherosclerotic diseases. Treg cells and their …